Autopsy report · NCT00481429
Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study
Cause of deathSlow enrollment
“Unable to recruit enough participants”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- Imperial College London
- Sponsor type
- University, hospital or other
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Rosiglitazone
- Participants
- 0
- Sites
- 4
- Countries
- United Kingdom
Trials that died the same way
- Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary Research
“failure to recruit enough number of participants” - Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
“Unable to recruit participants” - RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus Infection
“not able to recruit participants” - PD-HF: A Trial of Peritoneal Dialysis in Patients With Severe Heart Failure and Chronic Kidney Disease
“Inability to recruit adequate number of participants” - Attention Training for COVID-19 Related Distress
“Difficulty recruiting participants”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.